Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Time for shareholder activism?

<< Previous

Bullboard Posts

Next >>

Comment by Eileen68on Mar 30, 2023 5:14pm

159 Views

Post# 35370421

RE:RE:RE:RE:RE:RE:Time for shareholder activism?

Forget about my neurons - they are none of your business. One may however question your cognitive abilities. I'll let you in on something you must not know - we are the only ones waiting for a data read out. Yes; the lowly shareholders. Interested parties have real time data already by way of an NDA / Confidentiality agreement. Bottom line - I'm gonna lay low for a while longer and see what happens. Here's a truism you cannot deny (or can while exposing your own "neuron issues") Nothing changes if nothing changes.

<< Previous

Bullboard Posts

Next >>

FE Battery Metals begins 2024 winter drill program